UNIVERSITA' DEGLI STUDI DI BARI Patent applications |
Patent application number | Title | Published |
20150290167 | TRIMETHYLANGELICIN AS CFTR CORRECTOR IN BRONCHIAL EPITHELIAL CELLS - The invention relates to the use of 4,6,4′-trimethylangelicin (TMA) and structural analogues thereof to prepare a medicament for the treatment of cystic fibrosis with the primary objective of correcting the defective CFTR in a sub-group of cystic fibrosis patients consisting of patients carrying the F508de1-CFTR mutation. | 10-15-2015 |
20140312879 | METHOD TO REALIZE ELECTRONIC FIELD-EFFECT TRANSISTOR SENSORS - A transistor includes at least one conductive layer, at least one gate dielectric layer and at least one semiconducting film deposited on top of a receptor molecule layer previously deposited or covalently linked to the surface of the gate dielectric. The layer of biological material includes single or double layers of phospholipids, layers made of proteins such as receptors, antibodies, ionic channels and enzymes, single or double layers of phospholipids with inclusion or anchoring of proteins such as: receptors, antibodies, ionic channels and enzymes, layers made of oligonucleotide (DNA, RNA, PNA) probes, layers made of cells or viruses, layers made of synthetic receptors for example molecules or macromolecules similar to biological receptors for properties, reactivity or steric aspects. | 10-23-2014 |
20110288104 | Beta-3 receptor ligands and their use in therapy - The present invention relates to new compounds, ligands of the beta-3 adrenergic receptor, their preparation and their use in therapy or as research tools for said receptor; the invention also relates to a process for the preparation of the compounds of the invention and the use of inverse agonists of the beta-3 adrenergic receptor as medicaments. | 11-24-2011 |
20110217628 | CATALYST THIN LAYER AND METHOD FOR FABRICATING THE SAME - The catalyst thin layer consists of electronically conductive catalyst nano-particles embedded in a polymeric matrix. The ratio number of catalyst atoms/total number of atoms in the catalyst layer is comprised between 40% and 90%, more preferably between 50% and 60%. | 09-08-2011 |
20100140597 | Organic thin film transistors comprising thienyl oligomers and their use as gaseous phase sensors - This invention pertains to gaseous analytes sensor devices comprising organic thin film transistor and, in particular sensors able to perform the enantiomeric discrimination of gaseous analytes. The organic thin films are characterized by comprising a compound of formula (I). | 06-10-2010 |
20100076700 | SYSTEM FOR OPTICAL FIBER STRAIN MEASURE - A system measures the strain of an object. The system includes a laser source for generating an output radiation, a strainable optical fiber having first and second facets, and means for calculating a measure of a strain of the optical fiber. The first facet is coupled to the laser source for receiving the output radiation and for transmitting therefrom a guided radiation over the optical fiber towards the second facet. The second facet is adapted to receive the guided radiation and to reflect a corresponding reflected radiation towards the first facet. The laser source is a self-mixing type adapted to receive at least part of the reflected radiation and to mix the output radiation with the received radiation. The calculating means calculate the measure of the strain of the optical fiber through the linear displacement of the second section measured by the self-mixing effect in the laser source. | 03-25-2010 |
20100029576 | Diazoxide for the treatment of Friedreich's Ataxia - A pharmaceutical preparation treats Friedreich's ataxia and treats or prevents pathologies related thereto. In particular, the pharaceutical preparation concerns the use of diazoxide or 7-chloro-3-methyl-4H-1,2,4 benzothiadiazine 1,1-dioxide, in combination with glucose and/or leucine, for the treatment of Friedreich's ataxia (FRDA) and for the treatment or prevention of pathologies related thereto. | 02-04-2010 |
20080197048 | Use of bone marrow stromal cells for the treatment of tendons and/or ligaments damages - Object of the present invention is the use of bone marrow stromal cells, in particular autologous stromal cells, for the treatment of injuries to tendons and/or ligaments in mammals, in particular horses and especially racehorses. A further object of the present invention is a process for the treatment of injuries to tendons and/or ligaments in mammals that includes the delivery of bone marrow stromal cells, which are preferably autologous, into the lesions and a composition of bone marrow stromal cells, which are preferably autologous, for the treatment of the injured tendons and/or ligaments of a mammal, in particular a horse. | 08-21-2008 |